MARKER THERAPEUTICS, INC. Variable Lease, Cost
MARKER THERAPEUTICS, INC. (MRKR) reported Variable Lease, Cost of $109.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2023-05-15
- MARKER THERAPEUTICS, INC. variable lease, cost for the quarter ending 2023-03-31 was $109.00K, a 39.11% decline year-over-year.
- MARKER THERAPEUTICS, INC. variable lease, cost for the quarter ending 2022-12-31 was $82.00K, a 53.41% decline year-over-year.
- MARKER THERAPEUTICS, INC. variable lease, cost for the quarter ending 2022-09-30 was $161.00K, a 4.17% decline year-over-year.
- MARKER THERAPEUTICS, INC. variable lease, cost for the quarter ending 2022-06-30 was $226.00K, a 75.19% increase year-over-year.
- MARKER THERAPEUTICS, INC. variable lease, cost for fiscal 2022 was $648.00K, a 6.93% increase from fiscal 2021.
- MARKER THERAPEUTICS, INC. variable lease, cost for fiscal 2021 was $606.00K, a 262.87% increase from fiscal 2020.
- MARKER THERAPEUTICS, INC. variable lease, cost for fiscal 2020 was $167.00K, a 85.56% increase from fiscal 2019.
- MARKER THERAPEUTICS, INC. variable lease, cost for fiscal 2019 was $90.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-03-31 | $109.00K 10-Q · filed 2023-05-15 | $191.00K derived: sum of 2 quarters · filed 2023-05-15 | $352.00K derived: sum of 3 quarters · filed 2023-05-15 | $578.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $243.00K derived: sum of 2 quarters · filed 2023-03-22 | $469.00K derived: sum of 3 quarters · filed 2023-03-22 | $648.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $161.00K 10-Q · filed 2022-11-10 | $387.00K derived: sum of 2 quarters · filed 2022-11-10 | $566.00K 10-Q · filed 2022-11-10 | $742.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-06-30 | $226.00K 10-Q · filed 2022-08-11 | $405.00K 10-Q · filed 2022-08-11 | $581.00K derived: sum of 3 quarters · filed 2023-05-15 | $749.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2022-03-31 | $179.00K 10-Q · filed 2023-05-15 | $355.00K derived: sum of 2 quarters · filed 2023-05-15 | $523.00K derived: sum of 3 quarters · filed 2023-05-15 | $652.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $344.00K derived: sum of 2 quarters · filed 2023-03-22 | $473.00K derived: sum of 3 quarters · filed 2023-03-22 | $606.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $168.00K 10-Q · filed 2022-11-10 | $297.00K derived: sum of 2 quarters · filed 2022-11-10 | $430.00K 10-Q · filed 2022-11-10 | $512.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $129.00K 10-Q · filed 2022-08-11 | $262.00K 10-Q · filed 2022-08-11 | $344.00K derived: sum of 3 quarters · filed 2022-08-11 | $413.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $133.00K 10-Q · filed 2022-05-13 | $215.00K derived: sum of 2 quarters · filed 2022-05-13 | $284.00K derived: sum of 3 quarters · filed 2022-05-13 | $289.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $151.00K derived: sum of 2 quarters · filed 2022-03-17 | $156.00K derived: sum of 3 quarters · filed 2022-03-17 | $167.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $69.00K 10-Q · filed 2021-11-10 | $74.00K derived: sum of 2 quarters · filed 2021-11-10 | $85.00K 10-Q · filed 2021-11-10 | $114.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $5.00K 10-Q · filed 2021-08-10 | $16.00K 10-Q · filed 2021-08-10 | $45.00K derived: sum of 3 quarters · filed 2021-08-10 | $72.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-12 | $40.00K derived: sum of 2 quarters · filed 2021-05-12 | $67.00K derived: sum of 3 quarters · filed 2021-05-12 | $90.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $52.00K derived: sum of 2 quarters · filed 2021-03-09 | $75.00K derived: sum of 3 quarters · filed 2021-03-09 | $90.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $27.00K 10-Q · filed 2020-11-09 | $50.00K derived: sum of 2 quarters · filed 2020-11-09 | $65.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $23.00K 10-Q · filed 2020-08-10 | $38.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $15.00K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |